Bernadette Keane PhD

Bernadette Keane, Ph.D., Principal, Keane Consultancy Cell therapies are substantially more complex than small molecule or biological approaches to medicine. This complexity poses challenges for both academic groups and companies developing cell therapies, as well as for regulators seeking to oversee this growing area of medicine. In this interactive session, we will discuss some of the common challenges and lessons learned along the way and explore how collaborations between industry and regulators can help lead to the successful translation and commercialization of cell therapies.